Literature DB >> 19197985

Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: studies with sulforaphane and garlic organosulfur compounds.

Hui Nian1, Barbara Delage, Emily Ho, Roderick H Dashwood.   

Abstract

Histone deacetylase (HDAC) inhibitors reactivate epigenetically-silenced genes in cancer cells, triggering cell cycle arrest and apoptosis. Recent evidence suggests that dietary constituents can act as HDAC inhibitors, such as the isothiocyanates found in cruciferous vegetables and the allyl compounds present in garlic. Broccoli sprouts are a rich source of sulforaphane (SFN), an isothiocyanate that is metabolized via the mercapturic acid pathway and inhibits HDAC activity in human colon, prostate, and breast cancer cells. In mouse preclinical models, SFN inhibited HDAC activity and induced histone hyperacetylation coincident with tumor suppression. Inhibition of HDAC activity also was observed in circulating peripheral blood mononuclear cells obtained from people who consumed a single serving of broccoli sprouts. Garlic organosulfur compounds can be metabolized to allyl mercaptan (AM), a competitive HDAC inhibitor that induced rapid and sustained histone hyperacetylation in human colon cancer cells. Inhibition of HDAC activity by AM was associated with increased histone acetylation and Sp3 transcription factor binding to the promoter region of the P21WAF1 gene, resulting in elevated p21 protein expression and cell cycle arrest. Collectively, the results from these studies, and others reviewed herein, provide new insights into the relationships between reversible histone modifications, diet, and cancer chemoprevention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19197985      PMCID: PMC2701665          DOI: 10.1002/em.20454

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  88 in total

1.  Induction of histone acetylation and inhibition of growth of mouse erythroleukemia cells by S-allylmercaptocysteine.

Authors:  Michael A Lea; Mariam Rasheed; Verrell M Randolph; Faika Khan; Asif Shareef; Charles desBordes
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

Review 2.  Histone deacetylase inhibitors in cancer therapy.

Authors:  Roberto R Rosato; Steven Grant
Journal:  Cancer Biol Ther       Date:  2003 Jan-Feb       Impact factor: 4.742

3.  Acetylated histone H4 is reduced in human gastric adenomas and carcinomas.

Authors:  S Ono; N Oue; H Kuniyasu; T Suzuki; R Ito; K Matsusaki; T Ishikawa; E Tahara; W Yasui
Journal:  J Exp Clin Cancer Res       Date:  2002-09

4.  Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines.

Authors:  Keith B Glaser; Michael J Staver; Jeffrey F Waring; Joshua Stender; Roger G Ulrich; Steven K Davidsen
Journal:  Mol Cancer Ther       Date:  2003-02       Impact factor: 6.261

5.  Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane.

Authors:  Carmela Fimognari; Michael Nüsse; Rossano Cesari; Renato Iori; Giorgio Cantelli-Forti; Patrizia Hrelia
Journal:  Carcinogenesis       Date:  2002-04       Impact factor: 4.944

6.  A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis.

Authors:  Yih Lin Chung; Ming Yuan Lee; Ae June Wang; Lin Fen Yao
Journal:  Mol Ther       Date:  2003-11       Impact factor: 11.454

Review 7.  Epigenetic changes in colorectal cancer.

Authors:  Yutaka Kondo; Jean-Pierre J Issa
Journal:  Cancer Metastasis Rev       Date:  2004 Jan-Jun       Impact factor: 9.264

8.  Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells.

Authors:  Massimo Donadelli; Chiara Costanzo; Laura Faggioli; Maria Teresa Scupoli; Patrick S Moore; Claudio Bassi; Aldo Scarpa; Marta Palmieri
Journal:  Mol Carcinog       Date:  2003-10       Impact factor: 4.784

Review 9.  Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases.

Authors:  M Göttlicher
Journal:  Ann Hematol       Date:  2004       Impact factor: 3.673

10.  The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin.

Authors:  Lisa M Butler; Xianbo Zhou; Wei-Sheng Xu; Howard I Scher; Richard A Rifkind; Paul A Marks; Victoria M Richon
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-20       Impact factor: 11.205

View more
  57 in total

Review 1.  Mechanisms of action of isothiocyanates in cancer chemoprevention: an update.

Authors:  Sandi L Navarro; Fei Li; Johanna W Lampe
Journal:  Food Funct       Date:  2011-09-21       Impact factor: 5.396

2.  Epigenetics: A New Bridge between Nutrition and Health.

Authors:  Sang-Woon Choi; Simonetta Friso
Journal:  Adv Nutr       Date:  2010-11-16       Impact factor: 8.701

Review 3.  Targeting the epigenome with bioactive food components for cancer prevention.

Authors:  Thomas Prates Ong; Fernando Salvador Moreno; Sharon Ann Ross
Journal:  J Nutrigenet Nutrigenomics       Date:  2012-02-22

Review 4.  Dietary manipulation of histone structure and function.

Authors:  Emily Ho; Roderick H Dashwood
Journal:  World Rev Nutr Diet       Date:  2010-04-30       Impact factor: 0.575

5.  Liver histone H3 methylation and acetylation may associate with type 2 diabetes development.

Authors:  Peipei Tu; Xiaodan Li; Baicheng Ma; Huikun Duan; Yaofang Zhang; Ri Wu; Zaizhong Ni; Pingzhe Jiang; Haisong Wang; Miao Li; Jianhong Zhu; Minggang Li
Journal:  J Physiol Biochem       Date:  2015-02-10       Impact factor: 4.158

Review 6.  Epigenetic mechanisms in anti-cancer actions of bioactive food components--the implications in cancer prevention.

Authors:  B Stefanska; H Karlic; F Varga; K Fabianowska-Majewska; Ag Haslberger
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

Review 7.  Plant natural modulators in breast cancer prevention: status quo and future perspectives reinforced by predictive, preventive, and personalized medical approach.

Authors:  Sona Uramova; Peter Kubatka; Zuzana Dankova; Andrea Kapinova; Barbora Zolakova; Marek Samec; Pavol Zubor; Anthony Zulli; Vanda Valentova; Taeg Kyu Kwon; Peter Solar; Martin Kello; Karol Kajo; Dietrich Busselberg; Martin Pec; Jan Danko
Journal:  EPMA J       Date:  2018-11-12       Impact factor: 6.543

8.  A Review of Hydrogen Sulfide Synthesis, Metabolism, and Measurement: Is Modulation of Hydrogen Sulfide a Novel Therapeutic for Cancer?

Authors:  Xu Cao; Lei Ding; Zhi-Zhong Xie; Yong Yang; Matthew Whiteman; Philip K Moore; Jin-Song Bian
Journal:  Antioxid Redox Signal       Date:  2018-06-29       Impact factor: 8.401

9.  Dietary manipulation of histone structure and function.

Authors:  Emily Ho; Roderick H Dashwood
Journal:  J Nutrigenet Nutrigenomics       Date:  2011-04-06

10.  The role of Sulforaphane in cancer chemoprevention and health benefits: a mini-review.

Authors:  Reza Bayat Mokhtari; Narges Baluch; Tina S Homayouni; Evgeniya Morgatskaya; Sushil Kumar; Parandis Kazemi; Herman Yeger
Journal:  J Cell Commun Signal       Date:  2017-07-23       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.